Literature DB >> 20676957

Two single nucleotide polymorphisms in ALOX15 are associated with risk of coronary artery disease in a Chinese Han population.

Kai Zhang1, Yuan-yuan Wang, Qi-ji Liu, Hui Wang, Fang-fang Liu, Zhi-yong Ma, Yao-qin Gong, Li Li.   

Abstract

Arachidonate 12/15-lipoxygenase (12/15-LOX) has been implicated in the pathogenesis of atherosclerosis, but with contradicting results. The aim of this study was to investigate the association of two polymorphisms in ALOX15 and the risk of coronary artery disease (CAD) in a Chinese Han population. A total of 519 unrelated CAD patients and 608 unrelated control subjects of the Chinese Han population were recruited in the case-control study. Two tagSNPs, rs7217186:T>C and rs2619112:G>A, were selected and genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The carriers of the C allele (the CC homozygote and the CT heterozygote) of rs7217186:T>C and the carriers of the A allele (the AA homozygote and the GA heterozygote) of rs2619112:G>A displayed elevated odds ratios (ORs) for CAD compared with the TT homozygotes and GG homozygotes, respectively, after adjusting for other potential confounders including age, sex, body mass index, systolic blood pressure, diastolic blood pressure, glucose, triglyceride, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and smoking status (adjusted odds ratio [OR] = 3.2, 95% confidence interval [CI]: 1.335-7.665, P = 0.009 and adjusted OR = 3.5, 95% CI: 1.343-9.330, P = 0.011). In stratified analyses, after adjusting those aforementioned confounders, the CC and CT genotypes of rs7217186:T>C were associated with a greater risk of CAD in subjects <60 years (adjusted OR = 5.7, 95% CI: 1.557-21.097, P = 0.009) and in females (adjusted OR = 9.3, 95% CI: 1.048-82.213, P = 0.045). For rs2619112:G>A, subjects (<60 years) carrying the A allele had a greater risk of CAD than the GG homozygotes (adjusted OR = 4.9, 95% CI: 1.215-19.547, P = 0.025); the male carriers of A allele also had a greater risk (adjusted OR = 3.5, 95% CI: 1.136-11.006, P = 0.029). In summary, the present study shows that after adjustment for other confounding CAD factors, rs7217186:T>C and rs2619112:G>A of ALOX15 are associated with increased risk of CAD in this Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676957     DOI: 10.1007/s00380-009-1223-5

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  33 in total

1.  Evidence for 12-lipoxygenase induction in the vessel wall following balloon injury.

Authors:  R Natarajan; H Pei; J L Gu; J M Sarma; J Nadler
Journal:  Cardiovasc Res       Date:  1999-02       Impact factor: 10.787

2.  12/15-lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-kappaB.

Authors:  David T Bolick; A Wayne Orr; Angela Whetzel; Suseela Srinivasan; Melissa E Hatley; Martin A Schwartz; Catherine C Hedrick
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-09-15       Impact factor: 8.311

Review 3.  Genes and atherosclerosis: at the origin of the predisposition.

Authors:  P Puddu; E Cravero; G M Puddu; A Muscari
Journal:  Int J Clin Pract       Date:  2005-04       Impact factor: 2.503

Review 4.  Lipoxygenases and atherosclerosis: protection versus pathogenesis.

Authors:  M K Cathcart; V A Folcik
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

5.  Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells.

Authors:  R Natarajan; J Rosdahl; N Gonzales; W Bai
Journal:  Hypertension       Date:  1997-10       Impact factor: 10.190

6.  12/15-Lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo.

Authors:  Kelly B Reilly; Suseela Srinivasan; Melissa E Hatley; Mary Kim Patricia; Joanne Lannigan; David T Bolick; George Vandenhoff; Hong Pei; Rama Natarajan; Jerry L Nadler; Catherine C Hedrick
Journal:  J Biol Chem       Date:  2003-12-15       Impact factor: 5.157

7.  Genetic susceptibility to death from coronary heart disease in a study of twins.

Authors:  M E Marenberg; N Risch; L F Berkman; B Floderus; U de Faire
Journal:  N Engl J Med       Date:  1994-04-14       Impact factor: 91.245

8.  Induction of 15-lipoxygenase mRNA and protein in early atherosclerotic lesions.

Authors:  T Hiltunen; J Luoma; T Nikkari; S Ylä-Herttuala
Journal:  Circulation       Date:  1995-12-01       Impact factor: 29.690

9.  Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population.

Authors:  Patrícia Matos Biselli; Alexandre Rodrigues Guerzoni; Moacir Fernandes de Godoy; Erika Cristina Pavarino-Bertelli; Eny Maria Goloni-Bertollo
Journal:  Heart Vessels       Date:  2008-11-27       Impact factor: 2.037

10.  Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators.

Authors:  Aksam J Merched; Kerry Ko; Katherine H Gotlinger; Charles N Serhan; Lawrence Chan
Journal:  FASEB J       Date:  2008-06-17       Impact factor: 5.191

View more
  7 in total

Review 1.  Emerging cellular functions of the lipid metabolizing enzyme 15-Lipoxygenase-1.

Authors:  Melis Çolakoğlu; Sinem Tunçer; Sreeparna Banerjee
Journal:  Cell Prolif       Date:  2018-07-30       Impact factor: 6.831

2.  PoCos: Population Covering Locus Sets for Risk Assessment in Complex Diseases.

Authors:  Marzieh Ayati; Mehmet Koyutürk
Journal:  PLoS Comput Biol       Date:  2016-11-11       Impact factor: 4.475

3.  Association of ALOX15 gene polymorphism with ischemic stroke in Northern Chinese Han population.

Authors:  Jie Zhao; Zhiyi He; Shanshan Ma; Lei Li
Journal:  J Mol Neurosci       Date:  2012-02-19       Impact factor: 3.444

4.  Targeted deep resequencing of ALOX5 and ALOX5AP in patients with diabetes and association of rare variants with leukotriene pathways.

Authors:  Marek Postula; Piotr Kazimierz Janicki; Marek Rosiak; Ceren Eyileten; Małgorzata Zaremba; Agnieszka Kaplon-Cieslicka; Shigekazu Sugino; Dariusz Artur Kosior; Grzegorz Opolski; Krzysztof Jerzy Filipiak; Dagmara Mirowska-Guzel
Journal:  Exp Ther Med       Date:  2016-05-11       Impact factor: 2.447

5.  Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia.

Authors:  Sarah E Kleinstein; Laura Heath; Karen W Makar; Elizabeth M Poole; Brenna L Seufert; Martha L Slattery; Liren Xiao; David J Duggan; Li Hsu; Karen Curtin; Lisel Koepl; Jill Muehling; Darin Taverna; Bette J Caan; Christopher S Carlson; John D Potter; Cornelia M Ulrich
Journal:  Genes Chromosomes Cancer       Date:  2013-02-12       Impact factor: 5.006

6.  Characterization of a human 12/15-lipoxygenase promoter variant associated with atherosclerosis identifies vimentin as a promoter binding protein.

Authors:  Susmita Samanta; Kurtis Anderson; Sean Moran; David Hawke; David Gorenstein; Myriam Fornage
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

7.  Unique and Varied Contributions of Traditional CVD Risk Factors: A Systematic Literature Review of CAD Risk Factors in China.

Authors:  Joanne Foody; Yong Huo; Linong Ji; Dong Zhao; Dylan Boyd; Hai Jin Meng; Susan Shiff; Dayi Hu
Journal:  Clin Med Insights Cardiol       Date:  2013-04-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.